Walgreens has entered into an agreement with Abbott to sell the BinaxNOW Rapid Antigen Self Test over-the-counter in Walgreens stores nationwide. The test will be available nationwide for $23.99.
On March 31, 2021, Abbott received FDA Emergency Use Authorization for over-the-counter, non-prescription, asymptomatic use of its BinaxNOW COVID-19 Self Test for detection of COVID-19 infection. The new indication allows individuals with or without symptoms to have access to this test without a prescription.
Walgreens said, by May, it will expand testing to 6,000 drive-thru testing sites with half of these sites offering the no-cost, rapid Abbott ID NOW COVID-19 test.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.